AstraZeneca's Ultomiris Bags US FDA Nod to Treat Adults with NMOSD

AstraZeneca's Ultomiris (ravulizumab-cwvz) has been sanctioned in the United States as the initial and long-acting C5 supplement inhibitor for the treatment of grown-up patients with anti- aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis...

Pharma Giant Novo Nordisk Bags Deal To Expand into Cardio Business

The pharmaceutical firm Novo Nordisk has consented to purchase Cardior Pharmaceuticals for €1bn (£856bn) as it ventures into the cardiovascular pipeline. The Danish pharmaceutical drugmaker is building an arrangement of treatments in areas...

XRP Healthcare and Isansys Lifecare Team up To Transform Healthcare Services

XRP Healthcare announced a strategic alliance with Isansys Lifecare, a leading digital healthcare technology innovator, to improve Uganda's healthcare infrastructure and services. This cooperation is set to change patient consideration through the...

Aster MIMS Kozhikode and Qure.ai Partner To implement AI-powered Solution

In a huge step towards improving stroke care and determination, Aster MIMS Emergency Clinic in Kozhikode has joined hands with Qure.ai, a provider of AI solutions for clinical imaging. This cooperation presents a creative artificial intelligence...

WHO Develops Toolkit To Equip Medical Professionals to Tackle Climate Change

The World Health Organization (WHO) has developed a brand-new toolkit with the help of partners that aims to provide healthcare professionals with the knowledge and self-assurance they need to communicate health and climate change...

Bharat Biotech Initiates Clinical Trials of TB Vaccine on Adults

Leading vaccines & bio-therapeutics manufacturers, Bharat Biotech Global Ltd added that it began clinical preliminaries of the tuberculosis immunization Mtbvac on adults in India. This is the initial immunization against Tuberculosis from a human...

Dr Reddy's, Pharmazz Sign Licence Pact To Commercialise Novel Therapy

Leading pharmaceutical firm Dr. Reddy's Laboratories announced that it has signed a license agreement with US-based biopharma Pharmazz to commercialize the first-in-class breakthrough medication Centhaquine in India.  Centhaquine, developed by...

Social Media's Mental Health Impact: Safe Navigation in the Digital Age

In the current digital era, children and young adults have been immersed in technology since an early age. Computers, mobile devices, and the internet have become their constant companions.

WHO Releases New Guidelines for Drug Resistant TB Diagnosis

The World Health Organization (WHO) has recently published recommendations on the use of targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB).

Indian Businesses Lead CSR Health Projects: SoulAce Study

A recent study conducted by SoulAce, a consulting firm specializing in CSR (Corporate Social Responsibility) initiatives and monitoring & evaluation, reveals that Indian businesses have successfully spearheaded CSR health projects

© 2024 India Pharma Outlook. All Rights Reserved.